BSEM

BioStem Technologies Inc

1.30

Nov 12 • 3:59 PM ET -0.17 (-11.56%)

1.07

Aftermarket • 7:59 PM ET -0.23 (-17.69%)

Healthcare Biotechnology USA Nano NASD

Today, 6:50 PMBioStem reports $1.0 million cash and $8.8 million quarterly operating cash burn, highlighting liquidity and going-concern risks

Peers: MDXG ORGO SNWV HUMA TELA VCEL AXGN MESO ANIK ATRC

| Held by: VTI VXF

Scroll to Statements

Index	-
Market Cap	24.28M
Enterprise Value	18.54M
Income	-28.29M
Sales	34.59M
Book/sh	1.55
Cash/sh	0.37
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Oct 17, 2003

P/E	-
Forward P/E	-
PEG	-
P/S	0.70
P/B	0.84
P/C	3.49
P/FCF	-
EV/EBITDA	-
EV/Sales	0.54
Quick Ratio	0.76
Current Ratio	0.98
Debt/Eq	0.04
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-1.68
EPS next Y	-1.04
EPS next Q	-0.45
EPS this Y	-387.18%
EPS next Y	45.26%
EPS next 5Y	38.66%
EPS past 3/5Y	14.56% -7.36%
Sales past 3/5Y	90.44% 81.44%
EPS Y/Y TTM	-204.26%
Sales Y/Y TTM	-88.74%
EPS Q/Q	-1431.95%
Sales Q/Q	-83.98%
Earnings	Nov 12 AMC
EPS/Sales Surpr.	-48.84% 6.61%

Insider Own	31.80%
Insider Trans	0.00%
Inst Own	11.42%
Inst Trans	36.60%
ROA	-35.05%
ROE	-74.74%
ROIC	-102.44%
Gross Margin	76.08%
Oper. Margin	-67.47%
Profit Margin	-81.80%
SMA20	-6.07%
SMA50	-50.62%
SMA200	-67.40%
Trades

Shs Outstand	17.82M
Shs Float	12.73M
Short Float	2.25%
Short Ratio	1.58
Short Interest	0.29M
52W High	8.40 -84.52%
52W Low	1.00 30.00%
Volatility	27.71% 18.94%
ATR (14)	0.27
RSI (14)	38.34
Beta	0.68
Rel Volume	2.21
Avg Volume	181.45K
Volume	400,829

Perf Week	25.00%
Perf Month	-38.39%
Perf Quarter	-59.50%
Perf Half Y	-74.17%
Perf YTD	-65.88%
Perf Year	-72.04%
Perf 3Y	-54.39%
Perf 5Y	14.04%
Perf 10Y	-87.00%
Recom	1.00
Target Price	7.00
Prev Close	1.47
Price	1.30
Change %	-11.56%

Today 06:43PM	BioStem Beats On Revenue And Lifts Its Guidance Floor, But A $1 Million Cash Balance Makes Survival The Real Story (Earnings Whispers) -11.56% -17.69%
Nov-06-26 05:56PM	BioStem's Funding Fix Matters More Than Revenue As Stock Sinks Near $1 (Earnings Whispers) +8.65%
Sep-21-26 04:30PM	Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform (GlobeNewswire) -7.17% -9.55%
Aug-18-26 10:00AM	Sidoti Events, LLC's August Micro-Cap Virtual Conference (ACCESSWIRE) +5.00%
Aug-13-26 01:03AM	BioStem Technologies Inc (BSEM) (Q2 2026) Earnings Call Highlights: Revenue Surges to $7. ... (GuruFocus.com) -18.42%
09:25AM	Loading…
Aug-11-26 09:25AM	BioStem Technologies Inc (BSEM) Q2 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
Jun-09-26 10:50AM	BioStem Technologies Expands Board with Three Appointments as Nasdaq Uplisting Remains a Key Objective (BSEM) (InvestorsHub)

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FORTUNATO MICHAEL A	Chief Accounting Officer	Nov 09 '26	Option Exercise	0.00	970	0	69,634	Nov 10 04:30 PM
HASSETT BARRY	Chief Commercial Officer	Nov 01 '26	Option Exercise	0.00	253	0	5,256	Nov 03 04:30 PM
SMITH-VAN VURST ANDREW	Chief Operating Officer	Oct 07 '26	Option Exercise	2.00	250,000	500,000	1,789,809	Oct 09 04:30 PM
Matuszewski Jason	Chief Executive Officer	Oct 07 '26	Option Exercise	2.00	250,000	500,000	1,553,551	Oct 09 04:30 PM
POE BRANDON	Chief Financial Officer	Sep 15 '26	Option Exercise	0.00	1,694	0	58,062	Sep 17 04:30 PM
SMITH-VAN VURST ANDREW	Chief Operating Officer	Sep 17 '26	Option Exercise	0.00	9,574	0	1,539,809	Sep 17 04:30 PM
SMITH-VAN VURST ANDREW	Chief Operating Officer	Sep 15 '26	Option Exercise	0.00	7,622	0	1,530,235	Sep 17 04:30 PM
Matuszewski Jason	Chief Executive Officer	Sep 17 '26	Option Exercise	0.00	16,650	0	1,303,552	Sep 17 04:30 PM
Matuszewski Jason	Chief Executive Officer	Sep 15 '26	Option Exercise	0.00	8,469	0	1,286,902	Sep 17 04:30 PM
WARRINGTON KENNETH HOWARD JR	Director	Sep 15 '26	Option Exercise	0.00	1,694	0	33,928	Sep 17 04:30 PM
FORTUNATO MICHAEL A	Chief Accounting Officer	Sep 15 '26	Option Exercise	0.00	4,234	0	68,664	Sep 17 04:30 PM
HASSETT BARRY	Chief Commercial Officer	Sep 09 '26	Option Exercise	0.00	500	0	5,003	Sep 11 04:15 PM
UNGRODT JODI	Director	Aug 27 '26	Option Exercise	0.00	5,647	0	11,295	Aug 28 04:15 PM
Glickman Mark A	Director	Aug 27 '26	Option Exercise	0.00	7,671	0	7,671	Aug 28 04:15 PM
LESSER HANNAWAY RAYNA	Director	Aug 27 '26	Option Exercise	0.00	7,671	0	7,671	Aug 28 04:15 PM
WARRINGTON KENNETH HOWARD JR	Director	Aug 27 '26	Option Exercise	0.00	5,094	0	32,234	Aug 28 04:15 PM
SONENREICH STEVEN D	Director	Aug 27 '26	Option Exercise	0.00	7,671	0	7,671	Aug 28 04:15 PM
POE BRANDON	Chief Financial Officer	Aug 11 '26	Option Exercise	0.00	10,634	0	56,368	Aug 20 07:30 PM
FORTUNATO MICHAEL A	Chief Accounting Officer	Aug 09 '26	Option Exercise	0.00	970	0	64,430	Aug 20 07:30 PM

BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. It offers pre-treatment assessment, cell therapies, anti-aging, and wellness compounds. The company was founded by Andrew Smith Van Vurst, Henry W. Van Vurst IV, and Jason Matuszewski on April 29, 1939 and is headquartered in Pompano Beach, FL.

CEOMr. Jason V. Matuszewski

Chief Financial OfficerMr. Brandon Poe

COO & DirectorMr. Andrew Van Vurst CTBS

Chief Accounting OfficerMr. Michael A. Fortunato CPA

Vice President of Corporate Finance & StrategyMr. Noah Agron

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

BSEM

BioStem Technologies Inc

Upgrade your Finviz experience

All the Features.
Half the Price.